Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
NCT00037804
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Unspecified Adult Solid Tumor
Chemotherapy
Liver Dysfunction
Neoplasms, Solid Tumor
Interventions
DRUG:
Irinotecan
Sponsor
Pfizer